1. ScholarBank@NUS

DEEPIKA KANOJIA

rp01639

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
DEEPIKA KANOJIA
Variants
Kanojia D.
 
Main Affiliation
 
Faculty
 
Email
csidk@nus.edu.sg
 

Publications

Results 1-10 of 10 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
12015Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndromeMadan V. ; Kanojia D. ; Li J.; Okamoto R.; Sato-Otsubo A.; Kohlmann A.; Sanada M.; Grossmann V.; Sundaresan J.; Shiraishi Y.; Miyano S.; Thol F.; Ganser A.; Yang H. ; Haferlach T.; Ogawa S.; Koeffler H.P. 
22018Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progressionJiang Y. ; Jiang Y.-Y. ; Xie J.-J.; Mayakonda A. ; Hazawa M. ; Chen L.; Xiao J.-F. ; Li C.-Q.; Huang M.-L.; Ding L.-W. ; Sun Q.-Y. ; Xu L. ; Kanojia D. ; Jeitany M. ; Deng J.-W. ; Liao L.-D.; Soukiasian H.J.; Berman B.P.; Hao J.-J.; Xu L.-Y.; Li E.-M.; Wang M.-R.; Bi X.-G.; Lin D.-C. ; Koeffler H.P. 
32015Genomic landscape of liposarcomaKanojia, D ; Nagata, Y; Garg, M ; Lee, D.H ; Sato, A; Yoshida, K; Sato, Y; Sanada, M; Mayakonda, A ; Bartenhagen, C; Klein, H.-U; Doan, N.B; Said, J.W; Mohith, S; Gunasekar, S; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Myklebost, O; Yang, H ; Dugas, M; Meza-Zepeda, L.A; Silberman, A.W; Forscher, C; Tyner, J.W; Ogawa, S; Phillip Koeffler, H 
45-Apr-2019Identification of a novel enhancer of CEBPE essential for granulocytic differentiation.Shyamsunder, Pavithra ; Shanmugasundaram, Mahalakshmi; Mayakonda, Anand ; Dakle, Pushkar ; Teoh, Weoi Woon ; Han, Lin; Kanojia, Deepika ; Lim, Mei Chee ; Fullwood, Melissa ; An, Omer ; Yang, Henry ; Jizhong, Shi ; Hossain, Md Zakir ; Madan, Vikas ; Koeffler, H Phillip 
57-Oct-2019Identification of somatic alterations in lipoma using whole exome sequencingKanojia, Deepika ; Dakle, Pushkar ; Mayakonda, Anand ; Parameswaran, Rajeev ; Puhaindran, Mark E ; Min, Victor Lee Kwan ; Madan, Vikas ; Koeffler, Phillip 
62017Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targetsKanojia, D ; Garg, M ; Martinez, J; Anand, M.T ; Luty, S.B; Doan, N.B; Said, J.W; Forscher, C; Tyner, J.W; Koeffler, H.P 
72017Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcomaGarg, M ; Kanojia, D ; Mayakonda, A ; Said, J.W; Doan, N.B; Chien, W ; Ganesan, T.S; Chuang, L.S.H ; Venkatachalam, N; Baloglu, E; Shacham, S; Kauffman, M; Koeffler, H.P 
82017Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinGarg, M ; Kanojia, D ; Mayakonda, A ; Ganesan, T.S; Sadhanandhan, B; Suresh, S; Sneha, S; Nagare, R.P; Said, J.W; Doan, N.B; Ding, L.-W ; Baloglu, E; Shacham, S; Kauffman, M; Koeffler, H.P 
92013Sperm associated antigen 9 plays an important role in bladder transitional cell carcinomaKanojia D. ; Garg M.; Saini S.; Agarwal S.; Parashar D.; Jagadish N.; Seth A.; Bhatnagar A.; Gupta A.; Kumar R.; Lohiya N.K.; Suri A.
102014Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell linesKeerthy H.K.; Garg M. ; Mohan C.D.; Madan V. ; Kanojia D. ; Shobith R.; Nanjundaswamy S.; Mason D.J.; Bender A.; Basappa; Rangappa K.S.; Koeffler H.P.